Showing results (11-20 of 283) with videos related to
Sort By:
Pageof 29
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2022
Outcome of Patients with PSMA PET/CT Screen Failure by VISION Criteria and Treated with 177Lu-PSMA Therapy: A Multicenter Retrospective AnalysisMasatoshi Hotta, Andrei Gafita, Johannes Czernin, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 3, 2025
Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer: From CHAARTED to PSMA PET-An International Multicenter Retrospective StudyLena M Unterrainer, Thomas A Hope, Wolfgang P Fendler, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 9, 2023
Characterizing Normal Variant [68Ga]Ga-FAPI-46 Uptake in the EpididymisPeter George Maliha, Masatoshi Hotta, Johannes Czernin, et al.Clinical Advances in Hematology & Oncology : H&O|October 18, 2012
Antibody-drug conjugate technology development for hematologic disordersNeil H Bander, Myron S Czuczman, Anas YounesJournal of Visualized Experiments : Jove|June 5, 2014
In vitro method to observe E-selectin-mediated interactions between prostate circulating tumor cells derived from patients and human endothelial cellsGunjan Gakhar, Neil H Bander, David M NanusJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 2, 2026
Dosimetry Analysis of 177Lu-PSMA-I&T in Patients with Low-Volume Oligometastatic Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the LUNAR TrialZachary Ells, Catherine Meyer, Koichiro Kimura, et al.European Urology Focus|March 2, 2021
Emerging Prostate-specific Membrane Antigen-based Therapeutics: Small Molecules, Antibodies, and BeyondJones T Nauseef, Neil H Bander, Scott T TagawaJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 16, 2017
Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer RecurrenceJeremie Calais, Wolfgang P Fendler, Ken Herrmann, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 27, 2025
The Role of PSMA PET Parameters as Biomarkers for Response to PSMA-Targeted Radiopharmaceutical TherapyVishnu Murthy, Vinicius Ludwig, Andrei Gafita, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
PSMA PET/CT-Derived Indicators and Outcomes After [177Lu]Lu-PSMA-617: A Multicenter Retrospective Analysis from the U.S. Expanded-Access ProgramKoichiro Kimura, Vishnu Murthy, Andrew F Voter, et al.Pageof 29